Literature DB >> 23154499

Clinical characteristics of peripheral exudative hemorrhagic chorioretinopathy and its response to bevacizumab therapy.

E Y Pinarci, I Kilic, S A Bayar, S Sizmaz, I Akkoyun, G Yilmaz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23154499      PMCID： PMC3545371          DOI： 10.1038/eye.2012.239

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN： 0950-222X            Impact factor:   3.775


× No keyword cloud information.
  4 in total

1.  Intravitreal bevacizumab injection for peripheral exudative hemorrhagic chorioretinopathy.

Authors:  María Socorro Alforja; Noelia Sabater; Joan Giralt; Alfredo Adán; Laura Pelegrín; Ricardo Casaroli-Marano
Journal:  Jpn J Ophthalmol       Date:  2011-06-02       Impact factor: 2.447

2.  Peripheral exudative hemorrhagic chorioretinopathy in Korean patients.

Authors:  Yun Taek Kim; Se Woong Kang; Jeong-Hee Lee; Song Ee Chung
Journal:  Jpn J Ophthalmol       Date:  2010-06-25       Impact factor: 2.447

3.  Peripheral exudative hemorrhagic chorioretinopathy.

Authors:  W H Annesley
Journal:  Trans Am Ophthalmol Soc       Date:  1980

4.  Regression of serous macular detachment due to peripheral exudative hemorrhagic chorioretinopathy following intravitreal bevacizumab.

Authors:  Andrew J Barkmeier; Huseyin Kadikoy; Eric R Holz; Petros E Carvounis
Journal:  Eur J Ophthalmol       Date:  2011 Jul-Aug       Impact factor: 2.597
  4 in total
  5 in total

1.  [Unclear uveal tumor with bleeding].

Authors:  R Angermann; G Haas; M Hofer; M Stattin; N E Bechrakis; C Zehetner
Journal:  Ophthalmologe       Date:  2018-12       Impact factor: 1.059

2.  Anti-VEGF therapy in symptomatic peripheral exudative hemorrhagic chorioretinopathy (PEHCR) involving the macula.

Authors:  Ira Seibel; Annette Hager; Tobias Duncker; Aline I Riechardt; Daniela Nürnberg; Julian P Klein; Matus Rehak; Antonia M Joussen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-07-07       Impact factor: 3.117

3.  Clinical Features and Course of Patients with Peripheral Exudative Hemorrhagic Chorioretinopathy.

Authors:  Zafer Cebeci; Yasemin Dere; Şerife Bayraktar; Samuray Tuncer; Nur Kır
Journal:  Turk J Ophthalmol       Date:  2016-10-17

4.  Peripheral Exudative Hemorrhagic Chorioretinopathy with and without treatment-Clinical and multimodal imaging characteristics and prognosis.

Authors:  Margarita Safir; Ofira Zloto; Ido Didi Fabian; Iris Moroz; Dan D Gaton; Vicktoria Vishnevskia-Dai
Journal:  PLoS One       Date:  2022-09-27       Impact factor: 3.752

5.  Surgical Management of Hemorrhagic Retinal Detachment Secondary to Peripheral Exudative Hemorrhagic Chorioretinopathy.

Authors:  Valmore A Semidey; Abdulaziz A Al Taisan; Patrik Schatz; Ibrahim Taskintuna; Marco Mura
Journal:  Middle East Afr J Ophthalmol       Date:  2021-04-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.